Invention Grant
- Patent Title: Immunomodulators
-
Application No.: US15475227Application Date: 2017-03-31
-
Publication No.: US10358463B2Publication Date: 2019-07-23
- Inventor: Michael Matthew Miller , Martin Patrick Allen , Ling Li , Michael S. Bowsher , Eric P. Gillis , Eric Mull , Qian Zhao , Li-Qiang Sun , David R. Langley , Paul Michael Scola
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K38/12
- IPC: A61K38/12 ; C07K7/56 ; C07K7/08 ; C07K7/54 ; C07K7/64 ; A61K38/00
Abstract:
The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Public/Granted literature
- US20170283463A1 IMMUNOMODULATORS Public/Granted day:2017-10-05
Information query
IPC分类:
